Australian Dementia Network Limited

The Australian Dementia Network Limited (ADNeT Ltd, or ADNL) was established on 19 February 2020 as a not-for-profit company limited by guarantee to support the Australian Dementia Network (ADNeT) in achieving its strategic objective of furthering dementia research efforts across Australia.

ADNeT Ltd supports the network by:

  • generating additional income (particularly from industry for screening and trials activities, and potentially from states or philanthropic sources), and
  • more generally, coordinating dementia research funding and development throughout Australia.

Strategic Purposes

Establish an integrated network of dementia researchers, clinicians, service providers, industry, and consumers to drive this priority national translational research initiative;

Develop and maintain a clinical quality registry that can track, benchmark and report on the quality of clinical care of people with dementia and mild cognitive impairment to drive quality improvement, identify suitable and willing persons for clinical trials, and systematically collect longitudinal data for research on the determinants, epidemiology and trajectory of cognitive decline;

Establish a national network of memory clinics to optimise the assessment of cognitive disorders and improve specialist access for all Australians;

Develop a large, highly characterised cohort of people with dementia, or at increased risk of dementia, to populate a trials-ready cohort for participation in cutting-edge clinical trials and to study the natural history of dementia;

Connect with existing infrastructure supporting clinical trials in Australia to enhance the capacity for state-of-the-art assessments and the conduct of clinical trials nationwide; and

Integrate Australian research with the international effort to prevent or effectively treat dementia.

Collaborations

ADNeT Ltd has built and continuously strengthened partnerships with leading pharmaceutical organisations in the world as well as the Australian Government. Notable collaborative engagements over the past few years include:

  • Development of the ADNeT Registry Clinical Research Platform (CRP).
  • Recruiting and screening participants for various studies (AHEAD, EVOKE, Clarity amongst others) and referring suitable amyloid positive subjects to trial sites.
  • Conducting national survey of health professional experts within the ADNeT Memory Clinic network to characterise current clinical landscape in order to offer disease modifying therapies to eligible patients.
  • Genotyping for variants of TREM2.

Not-For-Profit Status

ADNeT Ltd is registered with the Australian Charities and Not-for-Profits Commission as a charitable organisation.

Board of Directors

Professor Peter Schofield

Interim Chair

Professor, School of Medical Sciences, University of NSW

Professor Christopher Rowe BMBS, FRACP, MD, FAANMS

Executive Director

Director, Australian Dementia Network, University of Melbourne
Director, Molecular Imaging Research, Austin Health
NHMRC Practitioner Fellow
Highly Cited Researcher 2016-2024 (Top 1% in Neuroscience)

Professor Sharon Naismith AM


Director, Healthy Brain Ageing Program, Brain and Mind Centre, UNSW
NHMRC Leadership Fellow
Leonard P Ullmann Chair in Psychology, Charles Perkins Centre

Graeme Prior

Chairman, Australian Alzheimer’s Research Foundation
CEO, Hall and Prior Residential Health and Aged Care Group

Greg Fraser BA, FAICA, FGIA

Not for Profit Board Director
Consultant to Public, Private, and Not For Profit Boards on corporate governance and risk management
Former Member ACT Ministerial Advisory Council on Ageing 
Dementia advocate 

Dr Jane Thompson BSc (Hons), MSc, PhD

Advocate for Public Involvement in Dementia research
Founding member of the former Alzheimer’s Australia Consumer Dementia Research Network
Former member of the NHMRC National Institute for Dementia Research Advisory Board

Professor Perminder Sachdev AM

Scientia Professor of Neuropsychiatry at UNSW Sydney
Co-Director of the Centre for Healthy Brain Ageing (CHeBA), UNSW
Clinical Director of the Neuropsychiatric Institute, Prince of Wales Hospital in Sydney

Professor Colin Masters AO

Professor, UWA Medical School
Laureate Professor, University of Melbourne

Cherry Santos

Company Secretary